Drugmakers were in the spotlight Wednesday as GSK recalls Zantac after U.S. regulators found probable cancer-causing impurities in the drug. Also in the U.S.: a jury says Johnson & Johnson must pay $ 8 billion in a case over male breast growth linked to Risperdal. David Pollard reports.


Reuters Video: Business